renasci.co.uk Report : Visit Site

Technical data of the renasci.co.uk

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host renasci.co.uk. Currently, hosted in United Kingdom and its service provider is Rackspace Ltd. .

the related websites

mbd-magazine.com bio2business.com biocity.co.uk 50states.com affinity.org.uk ceop.police.uk nhs.uk dailymail.co.uk globalcompetitionreview.com gov.scot linkagenet.com 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

home about about renasci leadership scientific team statisticians facilities academic collaborations sygnature discovery contact us contact details enquiry form consultancy experimental abuse & dependence drug discrimination self-administration tolerance and dependence other experimental options abuse liability testing collaboration (altec) treatment of substance use disorders cns receptor binding mouse microdialysis rat microdialysis culex bambino neurochemistry three component test rat model of binge-eating disorder evaluation of antipsychotics other behavioural assays immunohistochemistry and histology obesity & nash acute feeding studies behavioural specificity energy expenditure chronic feeding studies pair-feeding studies high fat fed rats dietary-induced obese animals genetically-obese animals drug-induced weight gain body composition analysis bomb calorimetry dexa cardiovascular measurements inhibition of gastric emptying lipolysis non-alcoholic steatohepatitis (nash) diabetes perifused pancreatic islets glucose tolerance tests metabolic parameters and biomarkers cobas c 111 analyser glucocorticoid-induced insulin resistance genetically-predisposed animals insulin resistance in dio animals stz/hfd model of type 2 diabetes diabetic complications adriamycin-induced nephropathy histology and immunohistochemistry news developing psychedelics into medicine: potential and pitfalls abuse liability assessment of cannabidiol iprecio micro infusion pumps webinar on assessment of drug abuse liability adriamycin-induced nephropathy model of ckd new nash flyer fda guidance on assessment of abuse potential of drugs renasci director becomes fbphs news archive 2016 news archive 2015 news archive 2014 news archive 2013 news archive 2012 events publications abuse & dependence/cns obesity & nash/diabetes home about about renasci leadership scientific team statisticians facilities academic collaborations sygnature discovery contact us contact details enquiry form consultancy experimental abuse & dependence drug discrimination self-administration tolerance and dependence other experimental options abuse liability testing collaboration (altec) treatment of substance use disorders cns receptor binding mouse microdialysis rat microdialysis culex bambino neurochemistry three component test rat model of binge-eating disorder evaluation of antipsychotics other behavioural assays immunohistochemistry and histology obesity & nash acute feeding studies behavioural specificity energy expenditure chronic feeding studies pair-feeding studies high fat fed rats dietary-induced obese animals genetically-obese animals drug-induced weight gain body composition analysis bomb calorimetry dexa cardiovascular measurements inhibition of gastric emptying lipolysis non-alcoholic steatohepatitis (nash) diabetes perifused pancreatic islets glucose tolerance tests metabolic parameters and biomarkers cobas c 111 analyser glucocorticoid-induced insulin resistance genetically-predisposed animals insulin resistance in dio animals stz/hfd model of type 2 diabetes diabetic complications adriamycin-induced nephropathy histology and immunohistochemistry news developing psychedelics into medicine: potential and pitfalls abuse liability assessment of cannabidiol iprecio micro infusion pumps webinar on assessment of drug abuse liability adriamycin-induced nephropathy model of ckd new nash flyer fda guidance on assessment of abuse potential of drugs renasci director becomes fbphs news archive 2016 news archive 2015 news archive 2014 news archive 2013 news archive 2012 events publications abuse & dependence/cns obesity & nash/diabetes consultancy expertise our successful track record in pharmaceutical r&d includes supporting >30 candidates into clinical development and 10 drugs to the market. experimental abuse & dependence renasci offers all mandatory abuse and dependence testing procedures for regulatory approval of cns-active drugs to glp. more information... cns we employ innovative techniques to test centrally-acting drugs including ex vivo binding, behavioural models and intracerebral microdialysis. more information... obesity & nash we have established a range of animal models for evaluating the potential of new drugs to treat obesity and nash. more information... diabetes our animal models of diabetes can also be used to study the effects of drugs on diabetic complications including nephropathy and neuropathy. more information... latest news developing psychedelics into medicine: potential and pitfalls, webinar on 27th november 10/11/2018 16:10:00 david heal will be taking part in a webinar on psychedelic drugs on tuesday 27th november read more... leadership renasci offers an integrated blend of consultancy and experimental services to all sectors of the global pharmaceutical industry. our team of experts are led by our founding three executive directors - sharon cheetham, rob jones and david heal meet the team... © copyright 2018 renasci ltd general links terms of use site map website privacy notice cookie policy accessibility

URL analysis for renasci.co.uk

http://www.renasci.co.uk/experimental/diabetes/diabetic-complications
http://www.renasci.co.uk/experimental/obesity--nash/dexa
http://www.renasci.co.uk/news/webinar-on-assessment-of-drug-abuse-liability
http://www.renasci.co.uk/news/news-archive-2013
http://www.renasci.co.uk/experimental/diabetes/stz-hfd-model-of-type-2-diabetes
http://www.renasci.co.uk/news/news-archive-2016
http://www.renasci.co.uk/news/adriamycin-induced-nephropathy
http://www.renasci.co.uk/about
http://www.renasci.co.uk/experimental/diabetes
http://www.renasci.co.uk/experimental/cns/mouse-microdialysis
http://www.renasci.co.uk/news
http://www.renasci.co.uk/about/about-renasci
http://www.renasci.co.uk/experimental/diabetes/perifused-pancreatic-islets
http://www.renasci.co.uk/experimental/abuse-and-dependence/treatment-of-substance-use-disorders
http://www.renasci.co.uk/experimental/obesity--nash/behavioural-specificity

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Error for "renasci.co.uk".

the WHOIS query quota for 2600:3c03:0000:0000:f03c:91ff:feae:779d has been exceeded
and will be replenished in 191 seconds

WHOIS lookup made at 20:59:16 19-Jul-2017

--
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:

Copyright Nominet UK 1996 - 2017.

You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.

  REFERRER http://www.nominet.org.uk

  REGISTRAR Nominet UK

SERVERS

  SERVER co.uk.whois-servers.net

  ARGS renasci.co.uk

  PORT 43

  TYPE domain

DISCLAIMER
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2017.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.

  REGISTERED no

DOMAIN

  NAME renasci.co.uk

NSERVER

  A.PRIM-NS.DE 194.163.252.5

  B.SEC-NS.DE 195.180.210.156

  C.SEC-NS.DE 195.180.210.33

  A.SEC-NS.DE 195.180.210.17

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .